Table of Contents
- Introduction
- Purpose of Tuberculosis Test Strips
- Mechanism of Tuberculosis Test Strips
- Parameters and Numerical Analysis
- QL Biotech Company Solutions
- References
Introduction
Tuberculosis (TB) is an infectious disease primarily affecting the lungs, caused by the bacterium Mycobacterium tuberculosis. Rapid and accurate diagnosis is critical in managing TB, and test strips are one of the tools used for this purpose.
Purpose of Tuberculosis Test Strips
Tuberculosis test strips are designed to provide a quick and accurate method for detecting the presence of Mycobacterium tuberculosis. These strips are often used in settings where traditional laboratory facilities are unavailable or for initial screenings.
Mechanism of Tuberculosis Test Strips
The strips work on the principle of immunochromatography. They typically consist of a nitrocellulose membrane where specific antibodies are fixed. When a sample is applied to the strip, it migrates along the membrane, and if TB antigens are present, they bind to the antibodies, producing a visible line as an indicator.
Parameters and Numerical Analysis
- Sensitivity: Tuberculosis test strips have a sensitivity range of 70% to 90%, meaning they correctly identify TB-positive cases within this range.
- Specificity: Specificity is approximately 85% to 95%, indicating the rate at which TB-negative cases are correctly identified.
- Time to Result: Results are typically available within 15 to 30 minutes after application.
- Sample Requirement: Only a small sample (approximately 5 µL) of whole blood, serum, or sputum is needed.
QL Biotech Company Solutions
QL Biotech company offers innovative solutions for TB diagnosis through advanced rapid test strip technology. Their products are designed to improve accuracy and reduce detection time. QL Biotech's TB test strips incorporate the latest molecular identification methods to ensure high sensitivity and specificity.
- Product Highlight: QL Rapid TB Test - Sensitivity: 92%, Specificity: 96%
- Advanced Method: Utilizes dual-antigen detection for enhanced accuracy.
- Global Reach: Deployed in over 30 countries with documented success in resource-limited settings.
References
- WHO Global Tuberculosis Report 2023.
- Nature Reviews Microbiology, Advances in Tuberculosis Diagnostics, 2022.
- Journal of Clinical Microbiology, Rapid Test Strip Evaluation in TB Diagnosis, 2021.
- QL Biotech Company Official Website: Product Specifications and Case Studies.